FDA Adverse Event Malfunction Summary report: N

NOVA MAX PLUS GLUCOSE MONITOR

MDR report key: 3994078 · Received July 24, 2014

Report

Report Number
3004193489-2014-00061
Event Type
Malfunction
Date Received
July 24, 2014
Date of Event
July 14, 2014
Report Date
July 14, 2014
Manufacturer
NOVA BIOMEDICAL CORP.
Product Code
CGA
PMA / PMN Number
K091547
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

TEST STRIP LOT #1020214027, EXP DATE: 01/01/2016. CONTROL SOLUTION LOT #1030214093, RANGE: 82-127 MG/DL. NOVA MAX TEST STRIP INSERT - QUALITY CONTROL CHECKING THE SYSTEM CONTROL SOLUTION TEST: THE NOVA MAX CONTROL SOLUTION IS USED AS A QUALITY CONTROL CHECK TO MAKE SURE THAT YOUR BLOOD GLUCOSE MONITOR AND THE NOVA MAX GLUCOSE TEST STRIPS ARE WORKING CORRECTLY. DO A CONTROL SOLUTION TEST: EACH TIME YOU OPEN A NEW VIAL OF TEST STRIPS. NOVA BIOMEDICAL AWAITS THE RETURN OF THE DEVICE FOR EVALUATION. SHOULD ANY SIGNIFICANT FINDINGS BE A RESULT OF THAT INVESTIGATION, A FOLLOW-UP REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO NOVA BIOMEDICAL THAT A CONSUMER RECEIVED A RESULT OF 266 MG/DL ON THEIR BLOOD GLUCOSE METER. THE CONSUMER IMMEDIATELY PERFORMED ANOTHER TEST USING THE SAME METER AND STRIPS FROM THE SAME VIAL GETTING THE FOLLOWING RESULT OF 115 MG/DL. A CONTROL SOLUTION TEST WAS PERFORMED WHILE TROUBLESHOOTING WITH CUSTOMER SUPPORT SHOWING THE TEST STRIPS TO FALL IN RANGE. THE DIFFERENCE IN THE CONSUMER'S READINGS WAS DETERMINED TO BE CLINICALLY SIGNIFICANT. THE METER AND TEST STRIPS WILL BE RETURNED FOR EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
435299 NOVA MAX PLUS GLUCOSE MONITOR GLUCOSE MONITOR CGA NOVA BIOMEDICAL CORP. NA 1020214027

Patients

Seq Age Sex Outcome Treatment
1 UNK